InsiderClue
← All stocks

Bicara Therapeutics Inc.

BCAX Net buying
CIK 0002023658 #2204 in the set updated 17 Sep 2026
Bought (12 mo)
$4.80M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$13.54M
$87.52K on a plan · $13.45M straight out of an exercise
Sold at will
$0.00
0 of 72 sales
Net
−$8.74M
+$4.80M against sales at will

By person

7 insiders · 79 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$4.80M (1)
—
+$4.80M
4,603,418
6.96%
$107.88M
+7.0%
Cohlhepp Ryan
President, COO & Interim CEO
—
$4.60M (29) scheduled
−$4.60M
181,641
0.2745%
$4.26M
−17.9%
Mazumdar Claire
Chief Executive Officer
—
$4.06M (17) scheduled
−$4.06M
362,152
0.5473%
$8.49M
+16.9%
Hyep Ivan
Chief Financial Officer
—
$3.24M (17) scheduled
−$3.24M
129,855
0.1962%
$3.04M
−10.7%
Raben David
Chief Medical Officer
—
$1.15M (8) scheduled
−$1.15M
55,286
0.0835%
$1.30M
+55.7%
Meisner Lara
Chief Legal Officer
—
$498.65K (1) scheduled
−$498.65K
0
0.0000%
$0.00
—
Flynn James E
10% owner
—
—
—
897,587
1.36%
$21.03M
—

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
Mazumdar Claire
16 Apr 2026
Chief Executive Officer
Exercised, kept
7,080
$5.45
$38.61K
Mazumdar Claire
16 Apr 2026
Chief Executive Officer
Exercised, kept
7,454
$3.79
$28.25K
Mazumdar Claire
16 Apr 2026
Chief Executive Officer
Exercised, kept
8,226
$4.44
$36.50K
Raben David
26 Dec 2025
Chief Medical Officer
Exercised, kept
19,789
$3.79
$75.00K
Cohlhepp Ryan
26 Dec 2025
President and COO
Exercised, kept
25,000
$4.44
$110.92K
Mazumdar Claire
16 Dec 2025
Chief Executive Officer
Exercised, kept
29,500
$5.45
$160.88K
Show all 79 transactions →

What was left out

Form 4 filings counted 62
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 69
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 677,756
History held since 16 Sep 2024